Moreover, despite the proposed nanosystem showed a successful targeting ability toward HER2-overexpressing breast cancer cells (the primary goal of this work), a detailed characterization of the antibody orientation, combined to the possibility to follow alternative functionalization strategies43, would allow further improving the nanomaterial targeting ability. This evidence concerns the gene ERBB2 and breast carcinoma.